Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial.

[1]  H. White,et al.  Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. , 2003, Journal of the American College of Cardiology.

[2]  J. Hochman,et al.  Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. , 2003, Circulation.

[3]  J. Gore,et al.  The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. , 2001, American heart journal.

[4]  L. Sleeper,et al.  Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. , 2001, American heart journal.

[5]  H. White,et al.  One-year survival following early revascularization for cardiogenic shock. , 2001, JAMA.

[6]  H. White.  Thrombolytic therapy in the elderly , 2000, The Lancet.

[7]  A. Jacobs,et al.  Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction : A report from the shock trial Registry , 2000 .

[8]  H. White,et al.  Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[9]  W. Spencer,et al.  Alcohol septal ablation in hypertrophic obstructive cardiomyopathy: the need for a registry. , 2000, Circulation.

[10]  N. Powe,et al.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. , 2000, Circulation.

[11]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[12]  J. Gurwitz,et al.  Temporal trends in cardiogenic shock complicating acute myocardial infarction. , 1999, The New England journal of medicine.

[13]  L. Sleeper,et al.  SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group. , 1999, American heart journal.

[14]  R. Califf,et al.  Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. , 1997, Circulation.

[15]  R. Califf,et al.  Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial , 1997, The Lancet.

[16]  A. Jacobs,et al.  Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on Mortality Results of an International Registry , 1995 .

[17]  J. Alpert,et al.  Cardiogenic shock after acute myocardial infarction: Incidence and Mortality from a Community-Wide Perspective, 1975 to 1988 , 1991 .

[18]  F. Harrell,et al.  Changing efficacy of coronary revascularization. Implications for patient selection. , 1988, Circulation.

[19]  M. Cohen,et al.  Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. , 1986, Circulation.